测序试剂市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00006817
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 211
Buy Now

2020年测序试剂市场规模为553032万美元,预计到2028年将达到1419560万美元;预计2020年至2028年复合年增长率为12.5%。

测序过程中使用测序试剂。这些试剂的使用很大程度上取决于要获得的所需结果。它们构成了测序反应的重要组成部分,也可用于各种其他应用。全球研发活动的增加预计将在预测期内推动市场的增长。

测序试剂市场根据试剂类型、技术、应用、最终用户和地理位置进行细分。按地域划分,市场分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美洲和中美洲。该报告提供了对测序试剂市场的见解和深入分析,重点关注市场趋势、技术进步和市场动态等参数,并分析了全球领先市场参与者的竞争格局。  

测序试剂市场利润丰厚的区域

市场洞察

五年以前,基因组测序仅限于研究环境。现在,它越来越多地应用于临床实践,在未来五年内,预计将在医疗保健领域生成来自超过 6000 万患者的基因组数据。基因组测序正在迅速转变为临床实践,医疗保健系统的实施得到了政府大量投资的支持,至少 14 个国家的投资总额超过 40 亿美元。这些国家基因组医学计划正在推动现实生活条件下的变革,同时解决实施障碍并收集证据以促进更广泛的采用,从而推动市场增长。
英国宣布了世界上最大的基因组项目作为这是慈善机构和制药公司之间 2 亿公私合作的一部分。英国已经通过十万基因组计划开发了世界上最大的基因组数据库。该项目由创新英国领导,作为英国研究与创新的一部分,将资助研究人员和行业,将英国卫生服务的数据和现实证据结合起来,创造出能够更早、更有效地诊断疾病的新产品和服务。
2018年11月,Stilla Technologies宣布完成由Illumina Ventures领投的1830万美元(1600万欧元)A轮融资。该公司将利用这笔资金将其 Naica 数字 PCR 系统商业化并开发临床应用。

2018 年 8 月,总部位于马萨诸塞州的波士顿公司宣布获得 430 万美元种子资金,并它将与基因组测序公司 Veritas Genetics 合作。这些资金将支持公司的使命,即通过创建一个值得信赖、安全和去中心化的基因组数据市场来开启个人基因组测序时代。
2020 年 4 月,MedGenome——一家位于班加罗尔的基因诊断、研究公司和数据公司——宣布在新一轮融资中筹集了 5500 万美元(约合 41.9 亿印度卢比),由全球影响力投资公司 LeapFrog Investments 领投。此外,MedGenome 声称已在印度的遗传诊断和研究合作伙伴关系中建立了最大的南亚遗传变异数据库。迄今为止,它已经完成了超过 200,000 项基因组测试,并从印度各地 550 多家医院和 6,000 名临床医生获取了样本。

因此,由于制造商和政府在基因组学领域的持续资助,测序预计试剂市场在预测期内将出现增长。

测序程序成本的下降对市场增长做出了重大贡献

基因组测序的成本已经大幅下降,是过去的近一百万倍六七年。近年来,二代测序价格大幅下降。例如,2000 年首次全人类基因组测序耗资超过 37 亿美元,历时十多年才完成。然而,近年来,同样的成本已降至 1,000 美元,而且过程所需的天数也更少。 2000年,测序成本为37亿美元,2006年降至1,000万美元,2012年降至5,000美元。成本下降可以通过基因组测序成本在2008年左右出现巨大差异来检验。 ,从大约 1000 万美元下降到目前的近 1000 美元。
许多测试服务的成本为几百美元,降低的成本和更高的速度不仅可以给他们带来更大的利润空间,处理速度更快并可能带来更高的消费者负载的能力。 Illumina 提供的最新机器是价格较低的设备,有两种型号可供选择——NovaSeq 5000 售价为 850,000 美元,NovaSeq 6000 售价为 985,000 美元。
成本的迅速降低现在对临床研究有所帮助,但效果更大速度和降低的价格点可能会吸引健康初创公司来帮助消费者。 2003年,首次全人类基因组测序耗资约27亿美元;然而,DNA测序公司Illumina推出了最新最先进的全基因组测序机器,而且价格不到100美元。基因组测序的价格自成立以来一直在持续直线下降。 2006年,Illumina的第一台机器用于人类基因组测序,成本为30万美元,2014年,该公司透露,相同测序的成本已降至1,000美元。 Illumina 和 Roche 等主要市场参与者推出了突破性技术,降低了测序成本和时间。
2003 年,国际人类基因组测序联盟开始通过对完整人类基因组进行测序来进行基因组分析。测序成本约为 26 亿美元(23 亿欧元)。到 2008 年,每个基因组的成本降至 140 万美元(100 万欧元)以下。外显子组测序的成本也变得更便宜。外显子组测序成本为 400 美元至 500 美元,基因组测序成本为 1,000 美元至 1,200 美元。由于基因组学领域的进步、不同测序方法和策略的发展等因素,测序成本显着下降。

技术洞察                   

根据技术,全球测序试剂市场分为二代测序、桑格测序和三代测序。 2020年,下一代测序细分市场占据最大份额。此外,预计到 2028 年,同一细分市场的市场将以最高速度增长。下一代测序是一种基于单分子测序原理或边合成边测序提供 RNA 或 DNA 片段大规模并行解码的技术。它产生大量测序数据,只能使用专用的生物信息学工具进行分析。这一因素可能会在预测期内增加全球对测序试剂的需求。

试剂类型见解

根据试剂类型,全球测序试剂市场分为对照试剂盒、文库试剂盒、模板试剂盒、测序试剂盒和其他试剂类型。控制套件细分市场在 2020 年占据最大的市场份额,预计到 2028 年将主导市场。簇生成、测序和比对的质量控制,以及串扰矩阵生成、定相和校准的校准控制预定相由对照试剂盒提供。

应用洞察

根据应用,全球测序试剂市场分为农业基因组学和法医学、临床调查、肿瘤学、生殖健康和其他应用。肿瘤学领域在 2020 年占据最大的市场份额,预计到 2028 年将主导市场。下一代测序 (NGS) 和生物信息学工具的结合有能力改变肿瘤学研究、诊断和治疗。< /p>

最终用户洞察

根据最终用户,全球测序试剂市场分为医院和诊所、研究机构、制药和生物技术公司等。医院和诊所细分市场在 2020 年占据最大的市场份额,预计到 2028 年将主导市场。医院和诊所是患者完成诊断并选择治疗方案和替代方案的主要接触点。   

测序试剂市场(按技术) 2020年和2028年

战略洞察

产品发布和并购是全球测序试剂市场参与者广泛采用的策略。下面列出了近期的一些关键产品开发:

2021 年 4 月,QIAGEN NV 推出了 QIAseq DIRECT SARS-CoV-2 试剂盒,这是一种病毒基因组富集和文库与 ARTIC 项目方案[基于引物的下一代测序 (NGS) 方法] 相比,该制备解决方案可显着减少文库周转时间和塑料使用量。

2018 年 12 月全球生命科学试剂和工具创新者 Abcam plc 与凯杰(苏州)转化医学有限公司(凯杰(苏州))签署谅解备忘录 (MoU) 协议,共同开发伴随诊断 (Companion Diagnostic) 的产品线。 CDx)和体外诊断试剂及试剂盒,以满足中国市场的特定需求。

COVID-19大流行对测序试剂市场产生积极影响。多家制药公司已开发出 COVID-19 疫苗,大多数国家也已开始接种疫苗。基因组测序已日益成为研究疾病爆发的重要工具,预计将在未来几个月对市场的其他领域产生积极影响。另一方面,由于全球运营停止而导致的供应链中断正在阻碍市场增长。

测序试剂 –市场细分

按技术

  • 下一代测序
  • 桑格测序
  • 第三代测序世代测序


按试剂类型

  • 对照试剂盒
  • 文库试剂盒
  • 模板试剂盒
  • 测序试剂盒
  • 其他试剂类型


按应用

  • 农业基因组学和法医学< /li>
  • 临床研究
  • 肿瘤学
  • 生殖健康
  • 其他应用


作者最终用户

  • 医院和诊所
  • 研究机构
  • 制药和生物技术公司
  • 其他最终用户
  • < /ul>


    按地理位置

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 法国
      • 德国
      • 英国
      • 意大利
      • 西班牙
      • 欧洲其他地区
    • 亚太地区 (APAC)
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太地区其他地区
    • 中东&非洲 (MEA)
      • 沙特阿拉伯
      • 南非
      • 阿联酋
      • 中东其他地区和地区非洲
    • 南美洲和中美洲 (SCAM)
      • 巴西
      • 阿根廷
      • 中南美洲其他地区美国

    公司简介

    • 华大基因集团
    • F。 Hoffmann-La Roche Ltd.
    • Fluidigm Corporation
    • Illumina, Inc.
    • LGC Biosearch Technologies
    • Pacific Biosciences of California, Inc.
    • Qiagen
    • Takara Bio, Inc.
    • Thermo Fisher Scientific, Inc.
    • Trilink Biotechnologies
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are sequencing reagents?

Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well. An increase in R&D activities worldwide is expected to drive the growth of the market during the forecast period.

What are the driving factors for the sequencing reagents market across the globe?

The factors that are driving growth of the market are growing funding for genomics, declining cost of sequencing procedures and increasing prevalence of chronic diseases are anticipated to drive the growth of the global sequencing reagents market during the forecast period. However, dearth of skilled professionals is hindering the market growth.

Who are the major players in the sequencing reagents market?

The sequencing reagents market majorly consists of the players such BGI Group, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Illumina, Inc., LGC Biosearch Technologies, Pacific Biosciences of California, Inc., Qiagen, Takara Bio, Inc., Thermo Fisher Scientific, Inc., and Trilink Biotechnologies among others.

The List of Companies - Sequencing Reagents Market

  1. BGI Group
  2. F. Hoffmann-La Roche Ltd.
  3. Fluidigm Corporation
  4. Illumina, Inc.
  5. LGC Biosearch Technologies
  6. Pacific Biosciences of California, Inc.
  7. Qiagen
  8. Takara Bio, Inc.
  9. Thermo Fisher Scientific, Inc.
  10. Trilink Biotechnologies

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports